Grail Leads a New Era of Early Cancer Detection

By National Alliance posted 02-08-2021 01:01 PM


Survival rates are higher when cancer is detected at earlier stages; however, effective screening exists only for a few cancer types and screenings have fallen sharply during the pandemic. This leads to most cancer being detected at later stages when survival rates are much lower. In fact, only 2 of 10 patients diagnosed with metastatic cancer will live 5+ years, compared to 9 of 10 patients who will live 5+ years when their cancer is detected early. Grail’s mission is to improve and save lives through early cancer detection, changing the trajectory of cancer mortality through innovative, safe, effective technology that can transform cancer control and care.